Feasibility of a Pragmatic PBPK Modeling Approach: Towards Model-Informed Dosing in Pediatric Clinical Care-Reference-Cited by-同舟云学术

Feasibility of a Pragmatic PBPK Modeling Approach: Towards Model-Informed Dosing in Pediatric Clinical Care

Published:2022-11-11 Issue:12 Volume:61 Page:1705-1717
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

van der Heijden Joyce E. M.^ORCID,Freriksen Jolien J. M.^ORCID,de Hoop-Sommen Marika A.^ORCID,van Bussel Lianne P. M.,Driessen Sander H. P.,Orlebeke Anne E. M.,Verscheijden Laurens F. M.^ORCID,Greupink Rick^ORCID,de Wildt Saskia N.^ORCID

Funder

Bill and Melinda Gates Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40262-022-01181-8.pdf

Reference46 articles.

1. Rodriguez W, et al. Improving pediatric dosing through pediatric initiatives: what we have learned. Pediatrics. 2008;121(3):530–9. https://doi.org/10.1542/peds.2007-1529.

2. The 2017 State of paediatric medicines in the EU commission report: 10 years of the EU Paediatric Regulation. 182. 3 May 2022. Available from: https://ec.europa.eu/health/system/files/2017-11/2017_childrensmedicines_report_en_0.pdf. Accessed: 3 May 2022.

3. Allen HC, et al. Off-label medication use in children, more common than we think: a systematic review of the literature. J Okla State Med Assoc. 2018;111(8):776–83.

4. Balan S, Hassali MAA, Mak VSL. Two decades of off-label prescribing in children: a literature review. World J Pediatr. 2018;14(6):528–40. https://doi.org/10.1007/s12519-018-0186-y.

5. Roberts R, et al. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA. 2003;290(7):905–11. https://doi.org/10.1001/jama.290.7.905.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Getting the dose right using physiologically-based pharmacokinetic modeling: dexamethasone to prevent post-extubation stridor in children as proof of concept;Frontiers in Pediatrics;2024-07-05

2. Assessment of self-perceived knowledge of key clinical pharmacology concepts and educational needs among European Paediatric Intensive Care Units: an ESPNIC survey;Intensive Care Medicine – Paediatric and Neonatal;2024-06-27

3. Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population;CPT: Pharmacometrics & Systems Pharmacology;2024-06-04

4. Expression of intestinal drug transporter proteins and metabolic enzymes in neonatal and pediatric patients;International Journal of Pharmaceutics;2024-04

5. Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care;Clinical Pharmacokinetics;2024-02-15